Blau Farmacêutica S.A.
BLAU3
Rank in Stocks
#13510
Blau Farmacêutica S.A. operates as a pharmaceutical enterprise, supplying... Blau Farmacêutica S.A. operates as a pharmaceutical enterprise, supplying private label medications across Brazil, Argentina, Colombia, the United States, Ecuador, Peru, and Uruguay. Its extensive product portfolio encompasses a broad spectrum of therapeutic areas, including immunology, hematology, oncology, nephrology, specialized treatments, and antibiotics. The company's offerings also extend to biological drugs, oral and injectable therapies for cancer, specialized treatments for infectious diseases, and a range of prescription and over-the-counter products like dermo-medicines and contraceptives, catering to both retail and non-retail markets. Additionally, Blau provides pharmaceuticals derived from blood, biological and biotechnological agents, and antiretroviral drugs. Its client base includes hospitals, private medical clinics, chemotherapy and hemodialysis centers, and public health institutions. Established in 1987, the firm's corporate headquarters are situated in Cotia, Brazil.
Share Price
$1.67
Last synced: 2026-11-10
Market Cap
$384.84M
Change (1 day)
0.00%
Change (1 year)
-10.19%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Blau Farmacêutica S.A. (BLAU3)
Category
Healthcare
Operating Margin for Blau Farmacêutica S.A. (BLAU3)
Operating Margin as of November 2026 TTM: 19.15%
According to Blau Farmacêutica S.A.'s latest financial reports, its current operating margin (TTM) is 19.15%. At the end of 2025 the company had an operating margin of 19.37%.
Operating Margin history for Blau Farmacêutica S.A. from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 19.15% | -1.14% |
| 2025 | 19.37% | -0.56% |
| 2024 | 19.48% | 26.41% |
| 2023 | 15.41% | -51.81% |
| 2022 | 31.98% | -4.37% |
| 2021 | 33.44% | 1.64% |
| 2020 | 32.90% | 6.75% |
| 2019 | 30.82% | 17.77% |
| 2018 | 26.17% | -0.87% |
| 2017 | 26.40% | 71.99% |
| 2016 | 15.35% | 7.12% |
| 2015 | 14.33% | -12.57% |
| 2014 | 16.39% | 16.49% |
| 2013 | 14.07% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -98.99% |
DE
|
|
| 19.68% | -98.97% |
DE
|
|
| 13.26% | -99.31% |
JP
|
|
| 17.08% | -99.11% |
CH
|
|
| 14.92% | -99.22% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Blau Farmacêutica S.A.'s operating margin
What is Blau Farmacêutica S.A.'s operating margin?
Blau Farmacêutica S.A.'s operating margin is 19.15%, as of Nov 2026.
What was Blau Farmacêutica S.A.'s operating margin in 2025?
In 2025, Blau Farmacêutica S.A.'s operating margin was 19.37%, compared with 19.48% in 2024.
How has Blau Farmacêutica S.A.'s operating margin changed since 2020?
From 2020 to 2025, Blau Farmacêutica S.A.'s operating margin was highest in 2021 (33.44%) and lowest in 2023 (15.41%).
How does Blau Farmacêutica S.A.'s operating margin compare with similar companies?
Blau Farmacêutica S.A.'s operating margin (19.15%) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.